Recruiting
Ulcerative colitis: WCS-IBD-6120
A Phase 2b study of an oral agent in moderate to severe disease after inadequate response to a biologic.
Home/Areas of Study/Inflammatory Bowel Disease
Our commitment to clinical research for inflammatory bowel disease
Ulcerative colitis and Crohn’s disease are lifelong conditions that often begin in a person’s twenties. Our studies evaluate new mechanisms of action for people whose current treatment has stopped working.
~1 in 3
people with IBD lose response to their first biologic within a year
6 studies in this area
Featured trials
A selection of what is open right now. Eligibility is decided by the investigator at a study site, never by this page.
Recruiting
Crohn’s disease: WCS-IBD-6155
A Phase 2 study evaluating a novel mechanism in participants with active disease.
Studies open and close continually. We can text you when a new one opens near you.
Get study alertsOur research
What are we studying?
Learn more about our areas of research and see whether one of our clinical trials might be right for you.
Ulcerative colitis
- Inflammation is continuous and confined to the large intestine, which makes it more predictable than Crohn’s but no easier to live with.
- Many people respond well to a first biologic and then lose that response over time.
- Our studies focus on what comes after that loss of response.
Crohn’s disease
- Inflammation can appear anywhere from mouth to anus and reaches through the whole bowel wall, which is why complications such as strictures and fistulas occur.
- Symptoms fluctuate, so studies measure endoscopic healing rather than relying on how a person reports feeling on a given day.
Want to understand what taking part actually involves before you go further?
Read the guide